GitLab [GTLB]
As of 2026-07-29. Framework v1.5.1. Tier-2 memo, cluster member (data & dev infrastructure).
Cluster analysis: reports/clusters/Data_Dev_Infrastructure_Cluster_2026-07-29.md
This memo issues no position verdict. The book decides.
Never fabricate a date. Every entry below is either (a) an exact date stated in a filing, or (b) an expected window inferred from the company's own filing history, with that history shown so the inference can be checked. Nothing here is invented, and where only a window is available it is labelled a window.
| Date | Event | Source | Why it matters |
|---|---|---|---|
| 2026-05-14 | Executive Chair Sytse Sijbrandij converted 15,134,451 Class B shares into Class A | 10-Q, equity note | Class B carries 10 votes per share. A conversion of this size materially reduces founder voting control — Class B outstanding is now 1.1 million against 167.8 million Class A. |
| Q1 FY2027 | First share repurchase in GitLab's history — $50,048k, against $50,061k of SBC in the same quarter (99.97%) | 10-Q, cash flow statement | If the quarterly rate holds, dilution stops. TTM coverage is only 24% because the programme is one quarter old. |
| 2026-03 | Annual charitable donation of 163,556 Class A shares to the GitLab Foundation approved, in four quarterly distributions | 10-Q | Recurring, ~$5.6m/yr at current prices. Related party — certain officers serve as Foundation directors. |
Q2 FY2027 (quarter ending 2026-07-31) — expected early September 2026.
Basis for the inference: this company's own earnings-release 8-K filing dates (item 2.02) in prior years were 2025-09-03, 2024-09-03. This is a pattern-based window, not a company-confirmed date. No date has been fabricated; if a confirmed date is required before acting, it must be taken from the company's investor-relations announcement.
Why this print is the one that matters for this name:
Three lines, in order:
Type: MEASURED. Time works for a long, so a dated event is not required to own this name — unlike a short.
| Dated events that would confirm or refute the implied path | yes — see §1 and §2 |
| Nearest catalyst | early September 2026 |
| Result | scored |
What the calendar deliberately does not contain: no product-launch dates, no conference dates, and no analyst-day dates have been included, because none was found stated in a filing. A fabricated catalyst date is worse than an absent calendar, and the absence is recorded rather than filled.
Type: MEASURED. Logged and scored on every name; it does not reject the name.
Named cause: DBNRR continuing through 110% while gross margin compresses 250bp/yr on Duo Agent inference cost, so revenue converges to the 15.2% RPO growth rate.
| Scenario | Implied price | vs spot | Probability |
|---|---|---|---|
| Growth to 12%, multiple to post-2024 min of 3.9x | $25.98 | -24% | 30% |
| Growth to 5%, multiple to 3.9x | $24.36 | -28% | 12% |
| Growth to 0%, multiple to 3.0x | $17.85 | -48% | 5% |
Going-concern: not argued. See §9 of the research document for the balance-sheet basis.
Full reasoning, the mechanism, and why the probabilities are what they are: GTLB_Research.md §9.